UniProt ID | P4K2A_HUMAN | |
---|---|---|
UniProt AC | Q9BTU6 | |
Protein Name | Phosphatidylinositol 4-kinase type 2-alpha | |
Gene Name | PI4K2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 479 | |
Subcellular Localization |
Golgi apparatus, trans-Golgi network membrane Lipid-anchor . Membrane raft . Cell projection, dendrite . Cell junction, synapse, presynaptic cell membrane . Cell junction, synapse, synaptosome . Mitochondrion . Endosome . Cytoplasmic vesicle . Membrane |
|
Protein Description | Membrane-bound phosphatidylinositol-4 kinase (PI4-kinase) that catalyzes the phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P), a lipid that plays important roles in endocytosis, Golgi function, protein sorting and membrane trafficking and is required for prolonged survival of neurons. Besides, phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P) is the first committed step in the generation of phosphatidylinositol 4,5-bisphosphate (PIP2), a precursor of the second messenger inositol 1,4,5-trisphosphate (InsP3).. | |
Protein Sequence | MDETSPLVSPERAQPPDYTFPSGSGAHFPQVPGGAVRVAAAAGSGPSPPGSPGHDRERQPLLDRARGAAAQGQTQTVAAQAQALAAQAAAAAHAAQAHRERNEFPEDPEFEAVVRQAELAIERCIFPERIYQGSSGSYFVKDPQGRIIAVFKPKNEEPYGHLNPKWTKWLQKLCCPCCFGRDCLVLNQGYLSEAGASLVDQKLELNIVPRTKVVYLASETFNYSAIDRVKSRGKRLALEKVPKVGQRFNRIGLPPKVGSFQLFVEGYKDADYWLRRFEAEPLPENTNRQLLLQFERLVVLDYIIRNTDRGNDNWLIKYDCPMDSSSSRDTDWVVVKEPVIKVAAIDNGLAFPLKHPDSWRAYPFYWAWLPQAKVPFSQEIKDLILPKISDPNFVKDLEEDLYELFKKDPGFDRGQFHKQIAVMRGQILNLTQALKDNKSPLHLVQMPPVIVETARSHQRSSSESYTQSFQSRKPFFSWW | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDETSPLV -------CCCCCCCC | 10.69 | 25944712 | |
4 | Phosphorylation | ----MDETSPLVSPE ----CCCCCCCCCCC | 31.23 | 29255136 | |
5 | Phosphorylation | ---MDETSPLVSPER ---CCCCCCCCCCCC | 17.75 | 29255136 | |
9 | Phosphorylation | DETSPLVSPERAQPP CCCCCCCCCCCCCCC | 28.82 | 29255136 | |
18 | Phosphorylation | ERAQPPDYTFPSGSG CCCCCCCCCCCCCCC | 18.96 | 28796482 | |
19 | Phosphorylation | RAQPPDYTFPSGSGA CCCCCCCCCCCCCCC | 36.13 | 25884760 | |
22 | Phosphorylation | PPDYTFPSGSGAHFP CCCCCCCCCCCCCCC | 41.21 | 25159151 | |
24 | Phosphorylation | DYTFPSGSGAHFPQV CCCCCCCCCCCCCCC | 36.82 | 29978859 | |
44 | Phosphorylation | RVAAAAGSGPSPPGS EEEHHCCCCCCCCCC | 42.69 | 29255136 | |
47 | Phosphorylation | AAAGSGPSPPGSPGH HHCCCCCCCCCCCCC | 47.45 | 19664994 | |
51 | Phosphorylation | SGPSPPGSPGHDRER CCCCCCCCCCCCCCC | 33.22 | 19664994 | |
124 | S-palmitoylation | AELAIERCIFPERIY HHHHHHHHCCCHHEE | 2.14 | 29575903 | |
134 | Phosphorylation | PERIYQGSSGSYFVK CHHEEECCCCCEEEE | 18.92 | 18785766 | |
137 | Phosphorylation | IYQGSSGSYFVKDPQ EEECCCCCEEEECCC | 19.83 | 28152594 | |
138 | Phosphorylation | YQGSSGSYFVKDPQG EECCCCCEEEECCCC | 18.86 | 28152594 | |
141 | Ubiquitination | SSGSYFVKDPQGRII CCCCEEEECCCCCEE | 54.51 | 23000965 | |
152 | Ubiquitination | GRIIAVFKPKNEEPY CCEEEEEECCCCCCC | 48.78 | 27667366 | |
159 | Phosphorylation | KPKNEEPYGHLNPKW ECCCCCCCCCCCHHH | 22.06 | 25839225 | |
165 | Ubiquitination | PYGHLNPKWTKWLQK CCCCCCHHHHHHHHH | 67.43 | 22817900 | |
168 | Ubiquitination | HLNPKWTKWLQKLCC CCCHHHHHHHHHHHC | 44.80 | 22817900 | |
174 | S-palmitoylation | TKWLQKLCCPCCFGR HHHHHHHHCHHHCCC | 2.91 | 22535966 | |
175 | S-palmitoylation | KWLQKLCCPCCFGRD HHHHHHHCHHHCCCC | 4.13 | 22535966 | |
177 | S-palmitoylation | LQKLCCPCCFGRDCL HHHHHCHHHCCCCEE | 1.55 | 22535966 | |
178 | S-palmitoylation | QKLCCPCCFGRDCLV HHHHCHHHCCCCEEE | 2.15 | 22535966 | |
234 | Ubiquitination | DRVKSRGKRLALEKV HHHHHHCCCHHHHCC | 43.03 | 23000965 | |
240 | Ubiquitination | GKRLALEKVPKVGQR CCCHHHHCCCCCCHH | 65.76 | 23000965 | |
240 | Methylation | GKRLALEKVPKVGQR CCCHHHHCCCCCCHH | 65.76 | - | |
243 | Ubiquitination | LALEKVPKVGQRFNR HHHHCCCCCCHHCCC | 63.08 | 23000965 | |
243 | Methylation | LALEKVPKVGQRFNR HHHHCCCCCCHHCCC | 63.08 | - | |
268 | Ubiquitination | QLFVEGYKDADYWLR EEEEECCCCHHHHHH | 58.24 | 21906983 | |
302 | Phosphorylation | ERLVVLDYIIRNTDR HHHHHHHHHHHCCCC | 8.29 | - | |
324 | Phosphorylation | KYDCPMDSSSSRDTD EEECCCCCCCCCCCC | 26.35 | 26471730 | |
325 | Phosphorylation | YDCPMDSSSSRDTDW EECCCCCCCCCCCCE | 28.24 | 26471730 | |
326 | Phosphorylation | DCPMDSSSSRDTDWV ECCCCCCCCCCCCEE | 33.09 | 26471730 | |
327 | Phosphorylation | CPMDSSSSRDTDWVV CCCCCCCCCCCCEEE | 35.80 | 26471730 | |
336 | Ubiquitination | DTDWVVVKEPVIKVA CCCEEEECCCEEEEE | 44.69 | 23000965 | |
341 | Ubiquitination | VVKEPVIKVAAIDNG EECCCEEEEEEEECC | 26.51 | 23000965 | |
354 | Ubiquitination | NGLAFPLKHPDSWRA CCEEECCCCCCCCCC | 54.02 | 21963094 | |
354 | Acetylation | NGLAFPLKHPDSWRA CCEEECCCCCCCCCC | 54.02 | 21466224 | |
373 | Ubiquitination | WAWLPQAKVPFSQEI EEECCCCCCCCCHHH | 45.23 | 21987572 | |
381 | Ubiquitination | VPFSQEIKDLILPKI CCCCHHHHHHHHHCC | 45.81 | 22817900 | |
387 | Ubiquitination | IKDLILPKISDPNFV HHHHHHHCCCCCCHH | 51.93 | 29967540 | |
402 | Phosphorylation | KDLEEDLYELFKKDP HCHHHHHHHHHHHCC | 23.94 | 25147952 | |
406 | Ubiquitination | EDLYELFKKDPGFDR HHHHHHHHHCCCCCH | 69.74 | 29967540 | |
407 | Ubiquitination | DLYELFKKDPGFDRG HHHHHHHHCCCCCHH | 62.92 | 29967540 | |
418 | Ubiquitination | FDRGQFHKQIAVMRG CCHHHHHHHHHHHHH | 44.69 | 29967540 | |
431 | Phosphorylation | RGQILNLTQALKDNK HHHHHHHHHHHHHCC | 15.66 | 20068231 | |
435 | Ubiquitination | LNLTQALKDNKSPLH HHHHHHHHHCCCCCC | 63.37 | 21906983 | |
438 | Ubiquitination | TQALKDNKSPLHLVQ HHHHHHCCCCCCCEE | 64.68 | 22817900 | |
456 | Phosphorylation | VIVETARSHQRSSSE EEEECCHHCCCCCCH | 22.85 | 23312004 | |
460 | Phosphorylation | TARSHQRSSSESYTQ CCHHCCCCCCHHHHH | 31.48 | 22167270 | |
461 | Phosphorylation | ARSHQRSSSESYTQS CHHCCCCCCHHHHHH | 40.07 | 22167270 | |
462 | Phosphorylation | RSHQRSSSESYTQSF HHCCCCCCHHHHHHH | 31.63 | 19664994 | |
464 | Phosphorylation | HQRSSSESYTQSFQS CCCCCCHHHHHHHHH | 35.11 | 22167270 | |
465 | Phosphorylation | QRSSSESYTQSFQSR CCCCCHHHHHHHHHC | 12.54 | 23927012 | |
466 | Phosphorylation | RSSSESYTQSFQSRK CCCCHHHHHHHHHCC | 27.32 | 22167270 | |
468 | Phosphorylation | SSESYTQSFQSRKPF CCHHHHHHHHHCCCC | 19.90 | 23927012 | |
471 | Phosphorylation | SYTQSFQSRKPFFSW HHHHHHHHCCCCCCC | 40.02 | 23927012 | |
473 | Ubiquitination | TQSFQSRKPFFSWW- HHHHHHCCCCCCCC- | 51.96 | 21963094 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of P4K2A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of P4K2A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HS90A_HUMAN | HSP90AA1 | physical | 21330372 | |
RD23A_HUMAN | RAD23A | physical | 21163940 | |
CLCB_HUMAN | CLTB | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-51; SER-462 ANDSER-464, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-47; SER-51 ANDSER-462, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461 AND SER-462, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-47; SER-51 ANDSER-462, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-9; SER-47 ANDSER-51, AND MASS SPECTROMETRY. |